Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E MacIntyre

Showing results (271-280 of 294) with videos related to

Pageof 30
Sort By:
Journal of Medicinal Chemistry|October 29, 2000
Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamideR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre studyP W Johnson, K Swinbank, S MacLennan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2023
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0B Kiesewetter, U Dafni, E G E de Vries, et al.
Leukemia|October 17, 2012
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALLR Garand, K Beldjord, H Cavé, et al.
Nature Genetics|September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massA S Chen, D J Marsh, M E Trumbauer, et al.
Leukemia|October 14, 2006
Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experienceC Picard, S Hayette, C Bilhou-Nabera, et al.
Allergy|April 19, 2016
Residential greenness is differentially associated with childhood allergic rhinitis and aeroallergen sensitization in seven birth cohortsE Fuertes, I Markevych, G Bowatte, et al.
Pageof 30

Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
Journal of Medicinal Chemistry|October 29, 2000
Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamideR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre studyP W Johnson, K Swinbank, S MacLennan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2023
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0B Kiesewetter, U Dafni, E G E de Vries, et al.
Leukemia|October 17, 2012
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALLR Garand, K Beldjord, H Cavé, et al.
Nature Genetics|September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massA S Chen, D J Marsh, M E Trumbauer, et al.
Leukemia|October 14, 2006
Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experienceC Picard, S Hayette, C Bilhou-Nabera, et al.
Allergy|April 19, 2016
Residential greenness is differentially associated with childhood allergic rhinitis and aeroallergen sensitization in seven birth cohortsE Fuertes, I Markevych, G Bowatte, et al.
Pageof 30